University of Ottawa Researchers Develop Precise Gene Therapy Delivery Using Small Extracellular Vesicles
Researchers at the University of Ottawa have made significant strides in the field of gene therapy by utilizing small extracellular vesicles (sEVs) to deliver RNA and other molecules to specific tissues in the body. This innovative approach, led by Dr. Derrick Gibbings, leverages the natural targeting abilities of sEVs, which are tiny, bubble-like structures that carry genetic material between cells. The research team discovered that the origin of these vesicles determines their destination within the body, allowing for precise delivery of therapeutic agents. This method has shown promise in targeting hard-to-reach organs such as the brain and kidneys, potentially revolutionizing the treatment of diseases that require gene-silencing therapies. 
